TD-1473 Dose B

DRUG2 trials

Sponsors

Theravance Biopharma

Conditions

Ulcerative Colitis (UC)

Phase 2

Efficacy & Safety of TD-1473 in Ulcerative Colitis

TerminatedNCT03758443

Theravance BiopharmaUlcerative Colitis (UC)

Start: 2019-03-11End: 2021-10-20Updated: 2022-11-15

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

TerminatedNCT03920254

Theravance BiopharmaUlcerative Colitis (UC)

Start: 2020-07-23End: 2021-10-27Updated: 2022-11-02